- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bret Jackson Outlines Findings, Origins, Next Steps of RAND Hospital Pricing Comparison Study
A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
Michigan recently participated in a RAND study comparing hospital prices for privately insured patients to a Medicare benchmark. What were the results?
The results showed wide variation of hospital prices, especially outpatient prices, across the country. And it was really staggering what the differences were from state to state. Michigan actually fared pretty well in having some of the lowest prices in the country. However, we know that our premiums are above average for the states that are in the study and that total spending of healthcare is high in Michigan. And so, now that we know that prices are low, we know that the problem lies in utilization.
This was version 2.0 of the RAND study. What was the purpose of it and how did it differ from the 1.0 version? What is next?
They had done the study, they had just looked at Indiana, and then afterwards they were like, “Okay, well this seems like it’s high, but we have no idea how that compares to anybody else,” because they had no benchmark. So the 2.0 study was a 25-state study, looking at how Indiana compared to all the other states that participated. Now we’re trying to look at a 3.0 study, where we’re trying for a 50-state strategy so we can compare how everybody’s doing.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
